150 related articles for article (PubMed ID: 15813736)
1. Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier.
Tomson FL; Viswanathan VK; Kanack KJ; Kanteti RP; Straub KV; Menet M; Kaper JB; Hecht G
Mol Microbiol; 2005 Apr; 56(2):447-64. PubMed ID: 15813736
[TBL] [Abstract][Full Text] [Related]
2. Function and distribution of EspG2, a type III secretion system effector of enteropathogenic Escherichia coli.
Smollett K; Shaw RK; Garmendia J; Knutton S; Frankel G
Microbes Infect; 2006 Jul; 8(8):2220-7. PubMed ID: 16781180
[TBL] [Abstract][Full Text] [Related]
3. Tricellular Tight Junction Protein Tricellulin Is Targeted by the Enteropathogenic Escherichia coli Effector EspG1, Leading to Epithelial Barrier Disruption.
Morampudi V; Graef FA; Stahl M; Dalwadi U; Conlin VS; Huang T; Vallance BA; Yu HB; Jacobson K
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795363
[TBL] [Abstract][Full Text] [Related]
4. EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri.
Elliott SJ; Krejany EO; Mellies JL; Robins-Browne RM; Sasakawa C; Kaper JB
Infect Immun; 2001 Jun; 69(6):4027-33. PubMed ID: 11349072
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function.
Viswanathan VK; Koutsouris A; Lukic S; Pilkinton M; Simonovic I; Simonovic M; Hecht G
Infect Immun; 2004 Jun; 72(6):3218-27. PubMed ID: 15155623
[TBL] [Abstract][Full Text] [Related]
6. Enteropathogenic Escherichia coli type III effectors EspG and EspG2 alter epithelial paracellular permeability.
Matsuzawa T; Kuwae A; Abe A
Infect Immun; 2005 Oct; 73(10):6283-9. PubMed ID: 16177299
[TBL] [Abstract][Full Text] [Related]
7. Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration.
Glotfelty LG; Zahs A; Hodges K; Shan K; Alto NM; Hecht GA
Cell Microbiol; 2014 Dec; 16(12):1767-83. PubMed ID: 24948117
[TBL] [Abstract][Full Text] [Related]
8. Enteropathogenic Escherichia coli type III effectors EspG and EspG2 disrupt the microtubule network of intestinal epithelial cells.
Shaw RK; Smollett K; Cleary J; Garmendia J; Straatman-Iwanowska A; Frankel G; Knutton S
Infect Immun; 2005 Jul; 73(7):4385-90. PubMed ID: 15972534
[TBL] [Abstract][Full Text] [Related]
9. Modulation of host cytoskeleton function by the enteropathogenic Escherichia coli and Citrobacter rodentium effector protein EspG.
Hardwidge PR; Deng W; Vallance BA; Rodriguez-Escudero I; Cid VJ; Molina M; Finlay BB
Infect Immun; 2005 May; 73(5):2586-94. PubMed ID: 15845460
[TBL] [Abstract][Full Text] [Related]
10. Enteropathogenic Escherichia coli inhibits butyrate uptake in Caco-2 cells by altering the apical membrane MCT1 level.
Borthakur A; Gill RK; Hodges K; Ramaswamy K; Hecht G; Dudeja PK
Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G30-5. PubMed ID: 16150873
[TBL] [Abstract][Full Text] [Related]
11. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.
McNamara BP; Koutsouris A; O'Connell CB; Nougayréde JP; Donnenberg MS; Hecht G
J Clin Invest; 2001 Mar; 107(5):621-9. PubMed ID: 11238563
[TBL] [Abstract][Full Text] [Related]
12. Translocation of enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its type III secretion system.
Martinez-Argudo I; Sands C; Jepson MA
Cell Microbiol; 2007 Jun; 9(6):1538-46. PubMed ID: 17298392
[TBL] [Abstract][Full Text] [Related]
13. Enteropathogenic
Tapia R; Kralicek SE; Hecht GA
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947656
[TBL] [Abstract][Full Text] [Related]
14. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein.
Dean P; Kenny B
Mol Microbiol; 2004 Nov; 54(3):665-75. PubMed ID: 15491358
[TBL] [Abstract][Full Text] [Related]
15. Modulation of tight junction barrier function by outer membrane proteins of enteropathogenic Escherichia coli: role of F-actin and junctional adhesion molecule-1.
Puthenedam M; Williams PH; Lakshmi BS; Balakrishnan A
Cell Biol Int; 2007 Aug; 31(8):836-44. PubMed ID: 17382565
[TBL] [Abstract][Full Text] [Related]
16. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli.
Thanabalasuriar A; Koutsouris A; Weflen A; Mimee M; Hecht G; Gruenheid S
Cell Microbiol; 2010 Jan; 12(1):31-41. PubMed ID: 19712078
[TBL] [Abstract][Full Text] [Related]
17. Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells.
Sharma R; Tesfay S; Tomson FL; Kanteti RP; Viswanathan VK; Hecht G
Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G685-94. PubMed ID: 16322091
[TBL] [Abstract][Full Text] [Related]
18. A gene from the locus of enterocyte effacement that is required for enteropathogenic Escherichia coli to increase tight-junction permeability encodes a chaperone for EspF.
Elliott SJ; O'Connell CB; Koutsouris A; Brinkley C; Donnenberg MS; Hecht G; Kaper JB
Infect Immun; 2002 May; 70(5):2271-7. PubMed ID: 11953359
[TBL] [Abstract][Full Text] [Related]
19. Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms.
Glotfelty LG; Hecht GA
Ann N Y Acad Sci; 2012 Jul; 1258():149-58. PubMed ID: 22731728
[TBL] [Abstract][Full Text] [Related]
20. Mechanism underlying inhibition of intestinal apical Cl/OH exchange following infection with enteropathogenic E. coli.
Gill RK; Borthakur A; Hodges K; Turner JR; Clayburgh DR; Saksena S; Zaheer A; Ramaswamy K; Hecht G; Dudeja PK
J Clin Invest; 2007 Feb; 117(2):428-37. PubMed ID: 17256057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
